CHAPTER 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tool & model
CHAPTER 2. EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT
2.2. CXO PERSPECTIVES
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Rise in demand of prebiotics in dietary supplements
3.4.1.2. Increasing consumer awareness regarding health benefits of prebiotics
3.4.1.3. Rise in use of prebiotics in poultry feed
3.4.1.4. Ease of incorporation into food & beverages
3.4.2. Restraints
3.4.2.1. High R&D cost
3.4.2.2. Larger market visibility of probiotics as compared to prebiotic ingredients
3.4.3. Opportunities
3.4.3.1. Emerging markets in Asia-Pacific region
CHAPTER 4. PREBIOTICS INGREDIENTS MARKET, BY INGREDIENTS
4.1. INTRODUCTION
4.1.1. Market size and forecast
4.2. INULIN
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. FRUCTO-OLIGOSACCHARIDES (FOS)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. GALACTO-OLIGOSACCHARIDES (GOS)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.5. FALACTO-FRUCTOSE (GF)
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
CHAPTER 5. PREBIOTICS INGREDIENTS MARKET, BY APPLICATION
5.1. INTRODUCTION
5.1.1. Market size and forecast
5.2. FOOD & BEVERAGES
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.2.1. Dairy Products
5.2.2.2. Bakery & Confectionery
5.2.2.3. Cereals
5.2.2.4. Meat Products
5.2.2.5. Sports Drinks
5.2.2.6. Others
5.3. DIETARY SUPPLEMENTS
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.2.1. Nutritional Supplements
5.3.2.2. Infant Nutrition
5.3.2.3. Specialty Nutrition
5.4. ANIMAL FEED
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.2.1. Poultry
5.4.2.2. Cattle
5.4.2.3. Swine
5.4.2.4. Pets
CHAPTER 6. PREBIOTICS INGREDIENTS MARKET, BY GEOGRAPHY
6.1. INTRODUCTION
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. U.S.
6.2.3.1. Market size and forecast, By Application
6.2.4. Canada
6.2.4.1. Market size and forecast, By Application
6.2.5. Mexico
6.2.5.1. Market size and forecast, By Application
6.3. EUROPE
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. UK
6.3.3.1. Market size and forecast, By Application
6.3.4. Germany
6.3.4.1. Market size and forecast, By Application
6.3.5. France
6.3.5.1. Market size and forecast, By Application
6.3.6. Italy
6.3.6.1. Market size and forecast, By Application
6.3.7. Rest of Europe
6.3.7.1. Market size and forecast, By Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Japan
6.4.3.1. Market size and forecast, By Application
6.4.4. China
6.4.4.1. Market size and forecast, By Application
6.4.5. India
6.4.5.1. Market size and forecast, By Application
6.4.6. Rest of Asia-Pacific
6.4.6.1. Market size and forecast, By Application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.5.3. Latin America
6.5.3.1. Market size and forecast, By Application
6.5.4. Middle East
6.5.4.1. Market size and forecast, By Application
6.5.5. Africa
6.5.5.1. Market size and forecast, By Application
CHAPTER 7. COMPANY PROFILES
7.1. BENEO GMBH
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.2. CARGILL INCORPORATED
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. E. I. DU PONT DE NEMOURS AND COMPANY
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. FRIESLANDCAMPINA
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.5. INGREDION INCORPORATED
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.6. SAMYANG GENEX
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.7. NEXIRA
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.8. BEGHIN MEIJI
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.9. ROYAL COSUN
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.10. YAKULT PHARMACEUTICAL INDUSTRY CO., LTD.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments